Stoycho Katsarov will ask for an extension of the epidemic situation to 6 months

By mid-December, the Ministry of Health will ensure the availability of all new therapies for the treatment of COVID.

This means that more vials of monoclonal antibodies will be purchased, with 3,000 doses already provided by one of the manufacturers, but a contract will be signed with another.

Our country will also buy from the only tablets so far against COVID – mulnopiravir by Merck, which the UK has already approved for the application. The European Medicines Agency (EMA) is also expected to approve their use by the end of November, with Bogdan Kirilov as head of the Bulgarian Medicines Agency. The first deliveries of the medicine in our country are expected by next month.

This was announced by the health authorities on Friday, specifying that in this way all forms of expression are covered with medication – mild, moderate and severe. However, the effectiveness they give in clinical trials is 50-60%, which

can not be

compare with that of

vaccines,

Minister of Health Stoycho Katsarov paid attention.

“They guarantee us that in 99% of cases, if he gets infected, we will not die and that in 9 out of 10 cases we will not even go to the hospital. “What drugs provide us with should not be taken wrong,” he said.

“In Bulgaria, monoclonal antibodies have already been delivered and distributed by one owner company. The criteria have been developed and disseminated to all hospitals and patients are currently being successfully treated with them. The procedure for import of a medicinal product of the other manufacturer of monoclonal antibodies is underway, and it is also expected to be on the market within 2-3 weeks “, said Dr. Desislava Velkovska, Director of the Pharmaceutical Policy Directorate, as a clarification, that this group of drugs can cover patients in medical to moderate condition who are not hospitalized.

For the most severe forms, remdesivir is used, from which country we have so far used more than 180,000 vials for therapy in about 25,000 patients.

For the mildest forms of COVID, the third ray of medicinal products is made – the antiviral in the form of tablets. It will be used in people over 12 years of age, and discharge should be done by the 5th day of home samples. The course of treatment is 5 days with 2 tablets per day. The GPs will be included in his discharge, but the patient’s path, ie. how it will be supplied with the pills is still being clarified.

With priority

outlines yes

people with

diabetes,

cardiovascular

condition,

obesity

etc., in which the risk of receipt increases.

The Ministry of Health will seek an extension of the anti-epidemic situation from 4 to 6 months from the Council of Ministers, Katsarov added.

The reason is that there is no prospect of the epidemic in our country ending sooner. The decision is currently until November 30, which will obviously be changed.